Qube Research & Technologies (QRT)’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.5M | Buy |
+1,829,670
| New | +$28.9M | 0.02% | 985 |
|
|
2025
Q4 | – | Sell |
-164,125
| Closed | -$2.41M | – | 3644 |
|
|
2025
Q3 | $2.41M | Sell |
164,125
-125,060
| -43% | -$2.14M | ﹤0.01% | 2147 |
|
|
2025
Q2 | $5.27M | Buy |
289,185
+41,699
| +17% | +$850K | 0.01% | 1665 |
|
|
2025
Q1 | $4.91M | Sell |
247,486
-355,281
| -59% | -$6.14M | 0.01% | 1544 |
|
|
2024
Q4 | $10.3M | Buy |
602,767
+294,685
| +96% | +$5.54M | 0.02% | 1066 |
|
|
2024
Q3 | $6.16M | Sell |
308,082
-108,339
| -26% | -$1.68M | 0.01% | 1286 |
|
|
2024
Q2 | $4.66M | Buy |
416,421
+228,077
| +121% | +$1.91M | 0.01% | 1288 |
|
|
2024
Q1 | $1.24M | Sell |
188,344
-583,127
| -76% | -$3.19M | ﹤0.01% | 2023 |
|
|
2023
Q4 | $3.49M | Sell |
771,471
-433,177
| -36% | -$1.6M | 0.01% | 1234 |
|
|
2023
Q3 | $4.31M | Buy |
1,204,648
+224,696
| +23% | +$865K | 0.01% | 1001 |
|
|
2023
Q2 | $3.62M | Buy |
979,952
+444,455
| +83% | +$1.65M | 0.01% | 805 |
|
|
2023
Q1 | $1.77M | Buy |
535,497
+493,424
| +1,173% | +$1.71M | 0.01% | 1059 |
|
|
2022
Q4 | $163K | Sell |
42,073
-250,890
| -86% | -$774K | ﹤0.01% | 1875 |
|
|
2022
Q3 | $712K | Buy |
+292,963
| New | +$703K | ﹤0.01% | 1331 |
|
|
2022
Q2 | – | Sell |
-148,080
| Closed | -$271K | – | 2435 |
|
|
2022
Q1 | $271K | Buy |
148,080
+43,520
| +42% | +$67.9K | ﹤0.01% | 1839 |
|
|
2021
Q4 | $147K | Buy |
104,560
+92,773
| +787% | +$122K | ﹤0.01% | 2056 |
|
|
2021
Q3 | $13K | Sell |
11,787
-120,800
| -91% | -$169K | ﹤0.01% | 2013 |
|
|
2021
Q2 | $212K | Buy |
132,587
+96,397
| +266% | +$170K | ﹤0.01% | 1765 |
|
|
2021
Q1 | $64K | Buy |
+36,190
| New | +$82.8K | ﹤0.01% | 1772 |
|
|
2020
Q3 | – | Sell |
-35,569
| Closed | -$104K | – | 1623 |
|
|
2020
Q2 | $104K | Buy |
+35,569
| New | +$102K | ﹤0.01% | 1512 |
|
Other funds holding ADMA
VCM
VPM
N
